New Key Statistics Module, Z-Score and F-Score
NAS:OCUP Key Ratios
| Market Cap $ M | 49.68 |
| Enterprise Value $ M | 32.31 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.97 |
| Price/Sales | 2.32 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 19.00 |
| EPS (TTM) $ | -0.48 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -152.30 |
| EV-to-EBIT | -3.24 |
| EV-to-EBITDA | -3.24 |
| PEG | -- |
| Shares Outstanding M | 25.61 |
| Net Margin (%) | -52.42 |
| Operating Margin % | -55.45 |
| Pre-tax Margin (%) | -52.36 |
| Quick Ratio | 13.35 |
| Current Ratio | 13.35 |
| ROA % (ttm) | -20.30 |
| ROE % (ttm) | -22.15 |
| ROIC % (ttm) | -339.68 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.46 |
OCUP Number of Guru Trades
OCUP Volume of Guru Trades
Gurus Latest Trades with NAS:OCUP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:OCUP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ocuphire Pharma Inc Insider Transactions
No Available Data
News about NAS:OCUP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers